1,3,4-Thiadiazole Derivatives as an Antimicrobial: An Update

Harigopal S. Sawarkar *

Dr. Rajendra Gode College of Pharmacy, Amravati, Maharashtra, India.

Mahavir Singh

School of Pharmacy, Jaipur National University, Jaipur, Rajasthan, India.

Birendra Shrivastav

School of Pharmacy, Jaipur National University, Jaipur, Rajasthan, India.

R. L. Bakal

Dr. Rajendra Gode College of Pharmacy, Amravati, Maharashtra, India.

*Author to whom correspondence should be addressed.


Abstract

Persistent and uncontrolled use of antibiotics results in development of bacterial resistant. The situation is getting worsen day by day and scientists are investigating thousands of potentially active drugs like molecule in laboratories around the world every day in search of effective antibiotics. During last decade considerable attention was given to five-member heterocyclic moieties while designing new antimicrobial agents. One of important heterocycle is five-membered 1,3,4-thiadiazole with unique bioisosteric properties displaying unusually wide spectrum of biological activities. This comprehensive review represent the recent 1,3,4-thiadiazole and its derivatives, which can be considered as potential antimicrobial agents in the period of 2015 and onwards. This review may help the medicinal chemists to develop new leads possessing 1,3,4-thiadiazole nucleus with higher efficacy and reduced side effects.

Keywords: 1,3,4-thiadiazole, anti-tubercular activity, antimicrobial activity, thiadiazole


How to Cite

Sawarkar, Harigopal S., Mahavir Singh, Birendra Shrivastav, and R. L. Bakal. 2021. “1,3,4-Thiadiazole Derivatives As an Antimicrobial: An Update”. Journal of Pharmaceutical Research International 33 (62A):232-57. https://doi.org/10.9734/jpri/2021/v33i62A35203.

Downloads

Download data is not yet available.